{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:50:53Z","timestamp":1786121453625,"version":"build-2736575974"},"reference-count":124,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>\n                    The emergence of convergent multidrug-resistant (MDR) and hypervirulent (\n                    <jats:italic>hvKp<\/jats:italic>\n                    ) lineages has transformed\n                    <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                    into a major global health threat. Frequently associated with hospital-acquired pneumonia, bacteremia, urinary tract infections (UTIs), meningitis, and sepsis, these strains disproportionately affect elderly, immunocompromised, and critically ill patients, resulting in high morbidity and mortality. Their rapid dissemination has further intensified the global antimicrobial resistance (AMR) crisis, highlighting the urgent need for therapeutic strategies beyond conventional antibiotics. Although bacteriophages have demonstrated considerable potential as antibacterial agents, their successful clinical application depends on factors extending beyond bacterial eradication alone. This review critically integrates current evidence on therapeutic efficacy, host\u2013phage immune interactions, delivery optimization, phage\u2013antibiotic synergy, phage-derived therapeutics, AI-assisted phage discovery, and translational considerations within a unified framework for\n                    <jats:italic>K. pneumoniae<\/jats:italic>\n                    infections. It further examines how these interconnected determinants collectively influence therapeutic outcomes and discusses emerging strategies for precision phage therapy. By adopting this integrated translational perspective, the review identifies the key factors governing successful clinical implementation and provides a framework for advancing bacteriophage therapy against multidrug-resistant\n                    <jats:italic>K. pneumoniae<\/jats:italic>\n                    infections.\n                  <\/jats:p>","DOI":"10.3389\/fmicb.2026.1913201","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T05:27:41Z","timestamp":1786080461000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Phage therapy against Klebsiella pneumoniae infections: integrating host\u2013phage immune interactions, therapeutic strategies, and clinical translation"],"prefix":"10.3389","volume":"17","author":[{"given":"John K.","family":"Giju","sequence":"first","affiliation":[{"name":"School of Biotechnology, Amrita Vishwa Vidyapeetham","place":["Kollam, Kerala, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Padmakumar","sequence":"additional","affiliation":[{"name":"School of Biotechnology, Amrita Vishwa Vidyapeetham","place":["Kollam, Kerala, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijith Pulimoottil","family":"Jaykumar","sequence":"additional","affiliation":[{"name":"School of Biotechnology, Amrita Vishwa Vidyapeetham","place":["Kollam, Kerala, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeesh","family":"Babu","sequence":"additional","affiliation":[{"name":"School of Biotechnology, Amrita Vishwa Vidyapeetham","place":["Kollam, Kerala, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind","family":"Madhavan","sequence":"additional","affiliation":[{"name":"School of Biotechnology, Amrita Vishwa Vidyapeetham","place":["Kollam, Kerala, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bipin G.","family":"Nair","sequence":"additional","affiliation":[{"name":"School of Biotechnology, Amrita Vishwa Vidyapeetham","place":["Kollam, Kerala, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha B.","family":"Kumar","sequence":"additional","affiliation":[{"name":"School of Biotechnology, Amrita Vishwa Vidyapeetham","place":["Kollam, Kerala, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1689974","DOI":"10.3389\/fmicb.2025.1689974","article-title":"Klebsiella pneumoniae: a multidrug-resistant pathogen, has emerged in Saudi Arabia","volume":"16","author":"Aldali","year":"2025","journal-title":"Front. Microbiol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jgar.2019.09.018","article-title":"Phage therapy for treatment of virulent Klebsiella pneumoniae infection in a mouse model","volume":"21","author":"Anand","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3390\/antibiotics10121508","article-title":"Global prevalence of nosocomial multidrug-resistant Klebsiella pneumoniae: a systematic review and meta-analysis","volume":"10","author":"Asri","year":"2021","journal-title":"Antibiotics"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1093\/nar\/gkaa856","article-title":"Seeker: alignment-free identification of bacteriophage genomes by deep learning","volume":"48","author":"Auslander","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1038\/s41467-024-47192-w","article-title":"Phage-specific immunity impairs efficacy of bacteriophage targeting vancomycin resistant Enterococcus in a murine model","volume":"15","author":"Berkson","year":"2024","journal-title":"Nat. Commun."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.medj.2024.05.017","article-title":"Neutralizing antibodies after nebulized phage therapy in cystic fibrosis patients","volume":"5","author":"Bernab\u00e9u-Gimeno","year":"2024","journal-title":"Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e3002341","DOI":"10.1371\/journal.pbio.3002341","article-title":"Mammalian cells internalize bacteriophages and use them as a resource to enhance cellular growth and survival","volume":"21","author":"Bichet","year":"2023","journal-title":"PLoS Biol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"102287","DOI":"10.1016\/j.isci.2021.102287","article-title":"Bacteriophage uptake by mammalian cell layers represents a potential sink that may impact phage therapy","volume":"24","author":"Bichet","year":"2021","journal-title":"iScience"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1038\/s41467-024-48675-6","article-title":"Prediction of Klebsiella phage-host specificity at the strain level","volume":"15","author":"Boeckaerts","year":"2024","journal-title":"Nat. Commun."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"127662","DOI":"10.1016\/j.micres.2024.127662","article-title":"Phage formulations and delivery strategies: unleashing the potential against antibiotic-resistant bacteria","volume":"282","author":"Bolsan","year":"2024","journal-title":"Microbiol. Res."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e1094","DOI":"10.1093\/infdis\/jiag096","article-title":"Immune responses to phage therapy in humans: a review","volume":"233","author":"Bosco","year":"2026","journal-title":"J. Infect. Dis."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e1012971","DOI":"10.1371\/journal.ppat.1012971","article-title":"Phage therapy for Klebsiella pneumoniae: understanding bacteria\u2013phage interactions for therapeutic innovations","volume":"21","author":"Bris","year":"2025","journal-title":"PLoS Pathog."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/s41586-026-10176-5","article-title":"Genome modelling and design across all domains of life with Evo 2","volume":"652","author":"Brixi","year":"2026","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1093\/cid\/ciaa705","article-title":"Phage therapy for limb-threatening prosthetic knee Klebsiella pneumoniae infection: case report and in vitro characterization of anti-biofilm activity","volume":"73","author":"Cano","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.3390\/pharmaceutics14071425","article-title":"Bacteriophage and bacterial susceptibility, resistance, and tolerance to antibiotics","volume":"14","author":"Chen","year":"2022","journal-title":"Pharmaceutics"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e01632-24","DOI":"10.1128\/msystems.01632-24","article-title":"Genomic analysis and therapeutic efficacy evaluation of bacteriophage PK2420 for pneumonia caused by hypervirulent Klebsiella pneumoniae (K20 serotype)","volume":"10","author":"Chen","year":"2025","journal-title":"mSystems"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"S126","DOI":"10.1093\/jbcr\/iraf019.162","article-title":"533 control acute Klebsiella pneumoniae infection in burn wounds with acidic cream","volume":"46","author":"Chen","year":"2025","journal-title":"J. Burn Care Res."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1397830","DOI":"10.3389\/fmicb.2024.1397830","article-title":"Engineered endolysin of Klebsiella pneumoniae phage is a potent and broad-spectrum bactericidal agent against \u201cESKAPEE\u201d pathogens","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Microbiol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"903682","DOI":"10.3389\/fcimb.2022.903682","article-title":"Clinical and microbiological characteristics of Bacteremic pneumonia caused by Klebsiella pneumoniae","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/joim.13007","article-title":"Hypervirulent Klebsiella pneumoniae \u2013 clinical and molecular perspectives","volume":"287","author":"Choby","year":"2020","journal-title":"J. Intern. Med."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3390\/biomedicines13051202","article-title":"Cytokines meet phages: a revolutionary pathway to modulating immunity and microbial balance","volume":"13","author":"Cianci","year":"2025","journal-title":"Biomedicine"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/antibiotics13090870","article-title":"A comprehensive review on phage therapy and phage-based drug development","volume":"13","author":"Cui","year":"2024","journal-title":"Antibiotics"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"110559","DOI":"10.1016\/j.virol.2025.110559","article-title":"Exploring deep learning in phage discovery and characterization","volume":"609","author":"de Paula Silva","year":"2025","journal-title":"Virology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13567-025-01600-1","article-title":"Beware of host immune responses towards bacteriophages potentially impacting phage therapy","volume":"56","author":"D\u00e9moulins","year":"2025","journal-title":"Vet. Res."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.chom.2021.11.014","article-title":"Bacteriostatic antibiotics promote CRISPR-Cas adaptive immunity by enabling increased spacer acquisition","volume":"30","author":"Dimitriu","year":"2022","journal-title":"Cell Host Microbe"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3390\/microorganisms14010201","article-title":"Bacteriophage therapy against Klebsiella Pneumoniae","volume":"14","author":"Ding","year":"2026","journal-title":"Microorganisms"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1691215","DOI":"10.3389\/fcimb.2025.1691215","article-title":"Combating Klebsiella pneumoniae: from antimicrobial resistance mechanisms to phage-based combination therapies","volume":"15","author":"Ding","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"100440","DOI":"10.1016\/j.opresp.2025.100440","article-title":"Phage therapy for respiratory tract infections","volume":"6","author":"Domingo-Calap","year":"2024","journal-title":"Open Respir. Arch."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"756","DOI":"10.2340\/17453674.2022.4579","article-title":"Salphage: salvage bacteriophage therapy for a recalcitrant Klebsiella pneumoniae prosthetic shoulder infection\u2014a case report","volume":"93","author":"Doub","year":"2022","journal-title":"Acta Orthop."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1611857","DOI":"10.3389\/fcimb.2025.1611857","article-title":"Optimizing phage therapy with artificial intelligence: a perspective","volume":"15","author":"Doud","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3390\/pharmaceutics17081077","article-title":"Latest advances in inhalable dry powder bacteriophage therapy for pulmonary infections","volume":"17","author":"Encinas-Basurto","year":"2025","journal-title":"Pharmaceutics"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41467-021-27656-z","article-title":"Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae","volume":"13","author":"Eskenazi","year":"2022","journal-title":"Nat. Commun."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"S423","DOI":"10.1093\/cid\/ciad515","article-title":"Use of bacteriophages to target intracellular pathogens","volume":"77","author":"Fajardo-Lubian","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3390\/antibiotics10091048","article-title":"Topically applied bacteriophage to control multi-drug resistant Klebsiella pneumoniae infected wound in a rat model","volume":"10","author":"Fayez","year":"2021","journal-title":"Antibiotics"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"107088","DOI":"10.1016\/j.ijantimicag.2024.107088","article-title":"Safety and efficacy of a phage cocktail on murine wound infections caused by carbapenem-resistant Klebsiella pneumoniae","volume":"63","author":"Feng","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3390\/microorganisms13020422","article-title":"Urinary tract infections caused by Klebsiella pneumoniae and prolonged treatment with trimethoprim\/sulfamethoxazole","volume":"13","author":"Filev","year":"2025","journal-title":"Microorganisms"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"106155","DOI":"10.1016\/j.jinf.2024.106155","article-title":"Risk of death in Klebsiella pneumoniae bloodstream infections is associated with specific phylogenetic lineages","volume":"88","author":"Fostervold","year":"2024","journal-title":"J. Infect."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1631359","DOI":"10.3389\/fcimb.2025.1631359","article-title":"Regulation of phage therapy medicinal products: developments, challenges, and opportunities","volume":"15","author":"Fuerst-Wilmes","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3390\/v17081080","article-title":"Biocontrol of phage resistance in Pseudomonas infections: insights into directed breaking of spontaneous evolutionary selection in phage therapy","volume":"17","author":"Fujiki","year":"2025","journal-title":"Viruses"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1038\/s41564-024-01832-5","article-title":"Prediction of strain level phage\u2013host interactions across the Escherichia genus using only genomic information","volume":"9","author":"Gaborieau","year":"2024","journal-title":"Nat. Microbiol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4014\/jmb.2601.01025","article-title":"Enhancing the antibacterial activity of endolysin against Klebsiella pneumoniae through fusion engineering using antimicrobial peptide Sub5","volume":"36","author":"Gao","year":"2026","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"100665","DOI":"10.1016\/j.microb.2026.100665","article-title":"Prevalence and antimicrobial resistance of ESKAPEE pathogens at ALERT hospital, Addis Ababa, Ethiopia: a one-year retrospective study","volume":"10","author":"Gebeyehu","year":"2026","journal-title":"Microbe"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12985-024-02450-7","article-title":"The potential use of bacteriophages as antibacterial agents against Klebsiella pneumoniae","volume":"21","author":"Gholizadeh","year":"2024","journal-title":"Virol. J."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1530819","DOI":"10.3389\/fmicb.2025.1530819","article-title":"Phage-antibiotic combinations against Klebsiella pneumoniae: impact of methodological approaches on effect evaluation","volume":"16","author":"Gorodnichev","year":"2025","journal-title":"Front. Microbiol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13054-026-05839-8","article-title":"Hospital-adapted inhaled phage therapy for ventilator-associated pneumonia caused by multidrug-resistant Klebsiella pneumoniae: a comparative pilot study","volume":"30","author":"Gorodnichev","year":"2026","journal-title":"Crit. Care"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3390\/microorganisms11030541","article-title":"The role of temperate phages in bacterial pathogenicity","volume":"11","author":"Gummalla","year":"2023","journal-title":"Microorganisms"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00034-21","article-title":"Bacteriophage treatment rescues mice infected with multidrug-resistant Klebsiella pneumoniae ST258","volume":"12","author":"Hesse","year":"2021","journal-title":"MBio"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3390\/ph18050724","article-title":"Hypervirulent Klebsiella pneumoniae: insights into virulence, antibiotic resistance, and fight strategies against a superbug","volume":"18","author":"Hetta","year":"2025","journal-title":"Pharmaceuticals"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1186\/s12889-024-20474-0","article-title":"Risk factors associated with multidrug-resistant Klebsiella pneumoniae infections: a multicenter observational study in Lebanese hospitals","volume":"24","author":"Itani","year":"2024","journal-title":"BMC Public Health"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1101\/2025.04.01.646603","article-title":"In-vivo efficacy of a phage cocktail therapy that targets ESBL-producing Klebsiella urinary tract infections clinical isolates","author":"Jariah","year":"2025","journal-title":"bioRxiv"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jconrel.2018.04.040","article-title":"Clearance of intracellular Klebsiella pneumoniae infection using gentamicin-loaded nanoparticles","volume":"279","author":"Jiang","year":"2018","journal-title":"J. Control. Release"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2147\/IDR.S502175","article-title":"A comprehensive overview of Klebsiella pneumoniae: resistance dynamics, clinical manifestations, and therapeutic options","volume":"18","author":"Jin","year":"2025","journal-title":"Infect. Drug Resist."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1630262","DOI":"10.3389\/fpubh.2025.1630262","article-title":"Global burden and trends of Klebsiella pneumoniae infection, 1990\u20132021: insights from the global burden of disease study","volume":"13","author":"Ju","year":"2025","journal-title":"Front. Public Health"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"28504","DOI":"10.1038\/s41598-025-07320-y","article-title":"Phage-mediated TLR2 signaling attenuates intracellular Mycobacterium abscessus survival in macrophages","volume":"15","author":"Kapoor","year":"2025","journal-title":"Sci. Rep."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/ijms27010172","article-title":"Analysis of pro- and anti-inflammatory gene response patterns in patients receiving phage therapy","volume":"27","author":"Kasprzak","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jgar.2024.01.018","article-title":"Evaluation of the therapeutic effect of a novel bacteriophage in the healing process of infected wounds with Klebsiella pneumoniae in mice","volume":"36","author":"Kelishomi","year":"2024","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"116318","DOI":"10.1016\/j.foodres.2025.116318","article-title":"Application of phage-derived enzymes for enhancing food safety","volume":"209","author":"Kim","year":"2025","journal-title":"Food Res. Int."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"e0135324","DOI":"10.1128\/aem.01353-24","article-title":"Challenges and opportunities of phage therapy for Klebsiella pneumoniae infections","volume":"90","author":"Kou","year":"2024","journal-title":"Appl. Environ. Microbiol."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"861374","DOI":"10.3389\/fcimb.2022.861374","article-title":"Urinary tract infections caused by K. pneumoniae in kidney transplant recipients\u2014epidemiology, virulence and antibiotic resistance","volume":"12","author":"Krawczyk","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"e01281","DOI":"10.1128\/AAC.01281-19","article-title":"A Dutch case report of successful treatment of chronic relapsing urinary tract infection with bacteriophages in a renal transplant patient","volume":"64","author":"Kuipers","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"e0042724","DOI":"10.1128\/spectrum.00427-24","article-title":"Exploring synergistic and antagonistic interactions in phage-antibiotic combinations against ESKAPE pathogens","volume":"12","author":"Kunz Coyne","year":"2024","journal-title":"Microbiol. Spectrum"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3390\/v14051079","article-title":"In vitro and in vivo assessments of two newly isolated bacteriophages against an ST13 urinary tract infection Klebsiella pneumoniae","volume":"14","author":"Lafor\u00eat","year":"2022","journal-title":"Viruses"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"e0141825","DOI":"10.1128\/mbio.01418-25","article-title":"mGem: immune recognition and clearance of bacteriophages\u2014implications for phage therapy","volume":"16","author":"Le","year":"2025","journal-title":"MBio"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"e00037-23","DOI":"10.1128\/aac.00037-23","article-title":"Therapeutic potential of intravenous phage as standalone therapy for recurrent drug-resistant urinary tract infections","volume":"67","author":"Le","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"e0324151","DOI":"10.1371\/journal.pone.0324151","article-title":"The global burden of Klebsiella pneumoniae-associated lower respiratory infection in 204 countries and territories, 1990\u20132021: findings from the global burden of disease study 2021","volume":"20","author":"Li","year":"2025","journal-title":"PLoS One"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1601.e1","DOI":"10.1016\/j.cmi.2023.08.022","article-title":"Development of phage resistance in multidrug-resistant Klebsiella pneumoniae is associated with reduced virulence: a case report of a personalised phage therapy","volume":"29","author":"Li","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"106218","DOI":"10.1016\/j.micpath.2023.106218","article-title":"Effective of phage cocktail against Klebsiella pneumoniae infection of murine mammary glands","volume":"182","author":"Liang","year":"2023","journal-title":"Microb. Pathog."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"e01462-20","DOI":"10.1128\/mbio.01462-20","article-title":"Phage-antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry","volume":"11","author":"Liu","year":"2020","journal-title":"MBio"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1137664","DOI":"10.3389\/fcimb.2023.1137664","article-title":"Clinical characteristics of respiratory tract infection caused by Klebsiella pneumoniae in immunocompromised patients: a retrospective cohort study","volume":"13","author":"Liu","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"877074","DOI":"10.3389\/fmicb.2022.877074","article-title":"Decolonization of carbapenem-resistant Klebsiella pneumoniae from the intestinal microbiota of model mice by phages targeting two surface structures","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"e01979-20","DOI":"10.1128\/AEM.01979-20","article-title":"Encapsulation and delivery of therapeutic phages","volume":"87","author":"Loh","year":"2021","journal-title":"Appl. Environ. Microbiol."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3390\/pathogens14101011","article-title":"Phage to ESKAPE: personalizing therapy for MDR infections\u2014a comprehensive clinical review","volume":"14","author":"Marino","year":"2025","journal-title":"Pathogens"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/bioinformatics\/bts014","article-title":"PHACTS, a computational approach to classifying the lifestyle of phages","volume":"28","author":"McNair","year":"2012","journal-title":"Bioinformatics"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"10883","DOI":"10.1038\/s41467-025-64608-3","article-title":"Considerations and perspectives on phage therapy from the transatlantic taskforce on antimicrobial resistance","volume":"16","author":"Moon","year":"2025","journal-title":"Nat. Commun."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"59","DOI":"10.18231\/j.ijmr.2020.013","article-title":"Pattern of antibiotic sensitivity among klebsiella isolates from sputum of hospital acquired respiratory tract infection","volume":"7","author":"More","year":"2025","journal-title":"Indian J. Microbiol."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"113513","DOI":"10.1016\/j.isci.2025.113513","article-title":"Transcriptomic analysis of phage-mammalian cell interaction reveals diverse phage immunobarcodes","volume":"28","author":"Muema","year":"2025","journal-title":"iScience"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/pathogens11050545","article-title":"Antimicrobial resistance and virulence characteristics of Klebsiella pneumoniae isolates in Kenya by whole-genome sequencing","volume":"11","author":"Muraya","year":"2022","journal-title":"Pathogens"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.cmi.2024.03.015","article-title":"Phage resistance in Klebsiella pneumoniae and bidirectional effects impacting antibiotic susceptibility","volume":"30","author":"Nang","year":"2024","journal-title":"Clin. Microbiol. Infect."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.46889\/JCIM.2025.6211","article-title":"First use of phage therapy in India for the treatment of a life-threatening, pan-drug-resistant Klebsiella pneumoniae periprosthetic joint infection","volume":"6","author":"Nath","year":"2025","journal-title":"J. Chem. Inf. Model."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"636078","DOI":"10.3389\/fimmu.2021.636078","article-title":"Better together: current insights into phagosome-lysosome fusion","volume":"12","author":"Nguyen","year":"2021","journal-title":"Front. Immunol."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3390\/ph18081115","article-title":"Bacteriophage therapy: discovery, development, and FDA approval pathways","volume":"18","author":"Niazi","year":"2025","journal-title":"Pharmaceuticals"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"1749949","DOI":"10.3389\/fcimb.2026.1749949","article-title":"A lytic bacteriophage vB_KpnP-6K2 inhibits ST11-KL64 Klebsiella pneumoniae induced cell death and inflammatory response","volume":"16","author":"Pan","year":"2026","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1093\/jac\/dkaf163","article-title":"Reversal of phenotypic resistance in multi-drug resistant carbapenemase-producing K. pneumoniae clinical isolates due to in vitro synergistic interactions between bacteriophages and antibiotics at clinically achievable concentrations","volume":"80","author":"Paranos","year":"2025","journal-title":"J. Antimicrob. Chemother."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"fuab019","DOI":"10.1093\/femsre\/fuab019","article-title":"The clinical path to deliver encapsulated phages and lysins","volume":"45","author":"Pinto","year":"2021","journal-title":"FEMS Microbiol. Rev."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/antibiotics14020186","article-title":"Antimicrobial resistance in ESKAPE pathogens: a retrospective epidemiological study at the University Hospital of Palermo, Italy","volume":"14","author":"Pipit\u00f2","year":"2025","journal-title":"Antibiotics"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/FEMSRE\/FUAA017","article-title":"Current challenges and future opportunities of phage therapy","volume":"44","author":"Pires","year":"2020","journal-title":"FEMS Microbiol. Rev."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","article-title":"Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study","volume":"9","author":"Pirnay","year":"2024","journal-title":"Nat. Microbiol."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1038\/s41467-024-46555-7","article-title":"Bacteriophage DNA induces an interrupted immune response during phage therapy in a chicken model","volume":"15","author":"Podlacha","year":"2024","journal-title":"Nat. Commun."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"e01145","DOI":"10.1128\/spectrum.01145-24","article-title":"In vivo evaluation of phage therapy against Klebsiella pneumoniae using the galleria mellonella model and molecular characterization of a novel Drulisvirus phage species","volume":"13","author":"Quispe-Villegas","year":"2025","journal-title":"Microbiol. Spectrum"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12866-023-02979-7","article-title":"Characterization of novel bacteriophage PSKP16 and its therapeutic potential against \u03b2-lactamase and biofilm producer strain of K2-Hypervirulent Klebsiella pneumoniae pneumonia infection in mice model","volume":"23","author":"Rahimi","year":"2023","journal-title":"BMC Microbiol."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"111754","DOI":"10.1016\/j.mehy.2025.111754","article-title":"Automated phage therapy in smart hospitals: a hypothesis for an AI, metagenomics, and IoT pipeline to treat resistant infections","volume":"203","author":"Rahimian","year":"2025","journal-title":"Med. Hypotheses"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1186\/s12879-019-4706-8","article-title":"Occurrence and determinants of Klebsiella species bloodstream infection in the western interior of British Columbia, Canada","volume":"19","author":"Reid","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"100605","DOI":"10.1016\/j.ijregi.2025.100605","article-title":"Klebsiella pneumoniae urinary tract infection: a multicentric study highlights significant regional variations in antimicrobial susceptibility across India","volume":"14","author":"Rizvi","year":"2025","journal-title":"IJID Reg."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.chom.2017.06.018","article-title":"Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen","volume":"22","author":"Roach","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"538060","DOI":"10.3389\/fmicb.2020.538060","article-title":"Local bacteriophage delivery for treatment and prevention of bacterial infections","volume":"11","author":"Rotman","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00001-19","article-title":"Hypervirulent Klebsiella pneumoniae","volume":"32","author":"Russo","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.3390\/v14112582","article-title":"Effects of Klebsiella pneumoniae bacteriophages on IRAK3 knockdown\/knockout THP-1 monocyte cell lines","volume":"14","author":"Schubert","year":"2022","journal-title":"Viruses"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/20415990.2024.2426824","article-title":"Phage therapeutic delivery methods and clinical trials for combating clinically relevant pathogens","volume":"16","author":"Selim","year":"2025","journal-title":"Ther. Deliv."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1038\/S41598-018-23418-Y","article-title":"Bacteriophages are more virulent to bacteria with human cells than they are in bacterial culture; insights from HT-29 cells","volume":"8","author":"Shan","year":"2018","journal-title":"Sci. Rep."},{"key":"ref100","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jgar.2024.07.019","article-title":"Evaluation of bacteriophage cocktail on urinary tract infection caused by colistin-resistant Klebsiella pneumoniae in mice model","volume":"39","author":"Singh","year":"2024","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"778676","DOI":"10.3389\/fphar.2022.778676","article-title":"Evaluation of bacteriophage cocktail on septicemia caused by Colistin-resistant Klebsiella pneumoniae in mice model","volume":"13","author":"Singh","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"e0153777","DOI":"10.1371\/journal.pone.0153777","article-title":"Encapsulation of bacteriophage in liposome accentuates its entry in to macrophage and shields it from neutralizing antibodies","volume":"11","author":"Singla","year":"2016","journal-title":"PLoS One"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1177\/26416549251412046","article-title":"Bacteriophages as immune modulators: current insights and future directions","volume":"7","author":"Somsri","year":"2026","journal-title":"Phage"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1186\/s12879-025-12120-w","article-title":"Global burden of Klebsiella pneumoniae infections and antimicrobial resistance in 2019","volume":"25","author":"Song","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"ref105","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/antibiotics14060545","article-title":"The current landscape of phage\u2013antibiotic synergistic (PAS) interactions","volume":"14","author":"Supina","year":"2025","journal-title":"Antibiotics"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1038\/s41467-025-57379-4","article-title":"Genomically defined hypervirulent Klebsiella pneumoniae contributed to early-onset increased mortality","volume":"16","author":"Tang","year":"2025","journal-title":"Nat. Commun."},{"key":"ref107","doi-asserted-by":"publisher","first-page":"e0142923","DOI":"10.1128\/aac.01429-23","article-title":"Host immunity involvement in the outcome of phage therapy against hypervirulent Klebsiella pneumoniae infections","volume":"68","author":"Tang","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"e00242-21","DOI":"10.1128\/mSystems.00242-21","article-title":"Component parts of bacteriophage virions accurately defined by a machine-learning approach built on evolutionary features","volume":"6","author":"Thung","year":"2021","journal-title":"mSystems"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41564-025-02202-5","article-title":"Phage resistance mutations in a marine bacterium impact biogeochemically relevant cellular processes","volume":"11","author":"Urvoy","year":"2026","journal-title":"Nat. Microbiol."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/v11010010","article-title":"Interactions between bacteriophage, bacteria, and the mammalian immune system","volume":"11","author":"Van Belleghem","year":"2018","journal-title":"Viruses"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3390\/pharmaceutics16030374","article-title":"Phage delivery strategies for biocontrolling human, animal, and plant bacterial infections: state of the art","volume":"16","author":"Vila","year":"2024","journal-title":"Pharmaceutics"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"78","DOI":"10.18231\/j.ijirm.2022.019","article-title":"Therapeutic effectiveness of bacteriophage in the treatment of pneumonia caused by NDM-4 producing in a mouse model","volume":"7","author":"VinodKumar","year":"2025","journal-title":"IP Indian J. Immunol. Respir. Med."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"566831","DOI":"10.2147\/IDR.S566831","article-title":"Necrotizing soft tissue infection caused by Klebsiella pneumoniae after intra-articular injection: a case report and literature review","volume":"19","author":"Wang","year":"2026","journal-title":"Infect. Drug Resist."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"758392","DOI":"10.3389\/fcimb.2021.758392","article-title":"Prospects of inhaled phage therapy for combatting pulmonary infections","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1042\/EBC20240024","article-title":"Phage-specific antibodies: are they a hurdle for the success of phage therapy?","volume":"68","author":"Washizaki","year":"2024","journal-title":"Essays Biochem."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"108075","DOI":"10.1016\/j.ijid.2025.108075","article-title":"Personalized aerosolized bacteriophage treatment of a pulmonary infection due to carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae in an infant","volume":"160","author":"Yan","year":"2025","journal-title":"Int. J. Infect. Dis."},{"key":"ref117","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1097\/CM9.0000000000003626","article-title":"Phage and enzyme therapies in wound infections: from lab to bedside","volume":"138","author":"Yang","year":"2025","journal-title":"Chin. Med. J."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13099-025-00735-y","article-title":"Recent insights on challenges encountered with phage therapy against gastrointestinal-associated infections","volume":"17","author":"Youssef","year":"2025","journal-title":"Gut Pathog."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"e00919-24","DOI":"10.1128\/aac.00919-24","article-title":"Bacteriophage treatment is effective against carbapenem-resistant Klebsiella pneumoniae (KPC) in a neutropenic murine model of gastrointestinal translocation and renal infection","volume":"69","author":"Zagaliotis","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref120","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3390\/ph16121638","article-title":"Phage therapy\u2014challenges, opportunities and future prospects","volume":"16","author":"Zalewska-Pi\u0105tek","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.1038\/s41467-025-61268-1","article-title":"Macrophage-induced reduction of bacteriophage density limits the efficacy of in vivo pulmonary phage therapy","volume":"16","author":"Zborowsky","year":"2025","journal-title":"Nat. Commun."},{"key":"ref122","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3390\/microorganisms14051027","article-title":"A new Endolysin Lys59: a broad-Spectrum phage Endolysin targeting both gram-negative and gram-positive Bacteria","volume":"14","author":"Zhang","year":"","journal-title":"Microorganisms"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"e00931","DOI":"10.1128\/spectrum.00931-25","article-title":"Characterization of the bacteriophage vB_KpnP_Henu1_3 lytic for K1 Klebsiella pneumoniae and its therapeutic efficacy in galleria mellonella larvae and mice","volume":"14","author":"Zhang","year":"","journal-title":"Microbiol. Spectrum"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"e00607","DOI":"10.1128\/msystems.00607-24","article-title":"Antibacterial effect of phage cocktails and phage-antibiotic synergy against pathogenic Klebsiella pneumoniae","volume":"9","author":"Zhao","year":"2024","journal-title":"mSystems"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1913201\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T05:27:43Z","timestamp":1786080463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1913201\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":124,"alternative-id":["10.3389\/fmicb.2026.1913201"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1913201","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"article-number":"1913201"}}